| Michael L Cohan, MD | |
|
133 E Brush Hill Rd, Suite 310, Elmhurst, IL 60126 | |
| (331) 221-9003 | |
| (331) 221-2743 |
| Full Name | Michael L Cohan |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 133 E Brush Hill Rd, Elmhurst, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144271297 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usrc - Villa Park Dialysis | Villa park, IL | Dialysis facility |
| Fmc - Elmhurst Dialysis Center | Elmhurst, IL | Dialysis facility |
| Usrc - Villa Park Home Therapies | Villa park, IL | Dialysis facility |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Edward Hospital | Naperville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Northern Illinois Ltd | 2163328675 | 97 |
| Elmhurst Memorial Healthcare | 9638168602 | 182 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
| Entity Name | Nephrology Associates Of Northern Illinois Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124069182 PECOS PAC ID: 2163328675 Enrollment ID: O20031208000313 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
| Entity Name | Elmhurst Memorial Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457493454 PECOS PAC ID: 9638168602 Enrollment ID: O20040506001298 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
| Entity Name | Nani-ihp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417376385 PECOS PAC ID: 3375767486 Enrollment ID: O20140611001371 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael L Cohan, MD 4201 Winfield Rd Fl 4, Warrenville, IL 60555-4025 Ph: (331) 221-6377 | Michael L Cohan, MD 133 E Brush Hill Rd, Suite 310, Elmhurst, IL 60126 Ph: (331) 221-9003 |
News Archive
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.
› Verified 1 days ago
William T O'rourke, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 E Schiller St, Elmhurst, IL 60126 Phone: 331-221-0000 Fax: 331-221-2312 | |
Maelen M Pantano, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 Schiller St, Elmhurst, IL 60126 Phone: 331-221-9001 Fax: 331-221-2315 | |
Ramier J Lehne, Nephrology Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9199 | |
Barbara E Potaczek, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-8952 Fax: 331-221-3782 | |
Dr. Lalitha Dileep-ansal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-8952 Fax: 331-221-3782 | |
Dr. Omar Shamsi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 S York St, Suite 1240, Elmhurst, IL 60126 Phone: 331-221-6140 Fax: 331-221-3838 | |
Dhara Naik, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 E Schiller St, Elmhurst, IL 60126 Phone: 331-221-0000 Fax: 331-221-2312 |